Investment in information technologies has by no means been confined to the United States and yet, average European or Japanese growth experience has been quite different.
The following are the key activities under the Working Party on Biotechnology (WPB).
This document reflects recent efforts made by the OECD to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.
Nine of these Organisations (CGIAR, CBD, FAO, OECD, OIE, UNCTAD, UNIDO, WHO and WTO) have projects related to safety in biotechnology and have agreed that it would be valuable to form the Inter-Agency Network for Safety in Biotechnology (IANB) t...
Biological Resource Centres (BRCs) are considered to be one of the key elements for sustainable international scientific infrastructure, which is necessary to underpin successful delivery of the benefits of biotechnology.
Water shortage and contamination are cause for increasing concern in many countries. Every year about 13 million people die from waterborne infections; of these, 2 million are children. The majority of deaths occur in developing countries. Howeve...
Genetic Testing Links.
This summary report discusses some questions raised on : what is a xenogeneic infectious disease event, and what are some of the problems associated with the development of a standardised case definition as well as practical framework for international surveillance.
Services are the driving force in OECD economies, accounting for at least 70% of GNP in many countries. However, their potential contribution is hampered by government policies that were designed for manufacturing industries.
Regulatory Developments in Xenotransplantation in Hungary.